Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Gust

Showing results (41-50 of 181) with videos related to

Pageof 19
Sort By:
Electrophoresis|December 21, 2010
MEKC as a powerful growing analytical techniqueSami El Deeb, Mohammed Abu Iriban, Ronald Gust
Archiv Der Pharmazie|December 15, 2004
Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell linesAnja Dullin, Francois Dufrasne, Michael Gelbcke, et al.
Archiv Der Pharmazie|September 5, 2002
Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexesFrancois Dufrasne, Michael Gelbcke, Beate Schnurr, et al.
European Journal of Medicinal Chemistry|December 5, 2024
Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stabilityMaximilian Gebhart, Mostafa Alilou, Ronald Gust, et al.
Archiv Der Pharmazie|December 31, 2002
Synthesis, structural evaluation, and estrogen receptor interaction of 4,5-bis(4-hydroxyphenyl)imidazolesRonald Gust, Roland Keilitz, Kathrin Schmidt, et al.
European Journal of Medicinal Chemistry|March 4, 2021
Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacyAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Journal of Medicinal Chemistry|July 26, 2002
(4R,5S)/(4S,5R)-4,5-Bis(4-hydroxyphenyl)-2-imidazolines: ligands for the estrogen receptor with a novel binding modeRonald Gust, Roland Keilitz, Kathrin Schmidt, et al.
European Journal of Medicinal Chemistry|October 25, 2019
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulatorsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cellsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 23, 2021
Determination of Relative Stabilities of Metal-Peptide Bonds in the Gas PhaseMonika Cziferszky, Dianna Truong, Christian G Hartinger, et al.
Pageof 19

Showing results (41-50 of 181) with videos related to

Sort By:
Pageof 19
Electrophoresis|December 21, 2010
MEKC as a powerful growing analytical techniqueSami El Deeb, Mohammed Abu Iriban, Ronald Gust
Archiv Der Pharmazie|December 15, 2004
Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell linesAnja Dullin, Francois Dufrasne, Michael Gelbcke, et al.
Archiv Der Pharmazie|September 5, 2002
Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexesFrancois Dufrasne, Michael Gelbcke, Beate Schnurr, et al.
European Journal of Medicinal Chemistry|December 5, 2024
Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stabilityMaximilian Gebhart, Mostafa Alilou, Ronald Gust, et al.
Archiv Der Pharmazie|December 31, 2002
Synthesis, structural evaluation, and estrogen receptor interaction of 4,5-bis(4-hydroxyphenyl)imidazolesRonald Gust, Roland Keilitz, Kathrin Schmidt, et al.
European Journal of Medicinal Chemistry|March 4, 2021
Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacyAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Journal of Medicinal Chemistry|July 26, 2002
(4R,5S)/(4S,5R)-4,5-Bis(4-hydroxyphenyl)-2-imidazolines: ligands for the estrogen receptor with a novel binding modeRonald Gust, Roland Keilitz, Kathrin Schmidt, et al.
European Journal of Medicinal Chemistry|October 25, 2019
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulatorsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cellsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 23, 2021
Determination of Relative Stabilities of Metal-Peptide Bonds in the Gas PhaseMonika Cziferszky, Dianna Truong, Christian G Hartinger, et al.
Pageof 19